Hemant Surgical Industries Ltd
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
- Market Cap ₹ 372 Cr.
- Current Price ₹ 285
- High / Low ₹ 367 / 88.2
- Stock P/E 36.0
- Book Value ₹ 94.4
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 3.02 times its book value
- Earnings include an other income of Rs.5.04 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | TTM | |
|---|---|---|
| 107 | 122 | |
| 98 | 109 | |
| Operating Profit | 9 | 13 |
| OPM % | 9% | 11% |
| 5 | 5 | |
| Interest | 2 | 3 |
| Depreciation | 1 | 1 |
| Profit before tax | 10 | 13 |
| Tax % | 23% | |
| 8 | 10 | |
| EPS in Rs | 7.70 | 8.85 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 113% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Sep 2025 | |
|---|---|---|
| Equity Capital | 10 | 13 |
| Reserves | 53 | 110 |
| 31 | 53 | |
| 54 | 39 | |
| Total Liabilities | 148 | 215 |
| 40 | 34 | |
| CWIP | 12 | 17 |
| Investments | 1 | 3 |
| 95 | 161 | |
| Total Assets | 148 | 215 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 9 | |
| -30 | |
| 18 | |
| Net Cash Flow | -4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | 70 |
| Inventory Days | 208 |
| Days Payable | 188 |
| Cash Conversion Cycle | 90 |
| Working Capital Days | 62 |
| ROCE % |
Documents
Announcements
-
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (LODR) Regulations 2015
12 Nov - No deviation in utilization of Rs. 2,848.00 lakh IPO proceeds; statement for half-year ended Sep 30, 2025.
-
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (LODR) Regulations 2015
12 Nov - No deviation in use of Rs61.53 crore raised Sept 16/18, 2025; ₹1,543.32L used, ₹4,609.38L balance.
-
Un-Audited Financial Results Of The Company For The Half Year Ended On September 30, 2025.
12 Nov - Board approved unaudited H1 results to Sept 30, 2025; revenue Rs6,426.06L; raised Rs6,152.71L; Rs4,609.38L balance.
-
Board Meeting Outcome for Held On Wednesday November 12, 2025
12 Nov - Board approved H1 (Sep 30, 2025) results; PAT ₹540.53L; raised ₹6,152.71L via equity and warrants.
-
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For Half Year Ended On September 30, 2025
5 Nov - Board meeting Nov 12, 2025 to approve unaudited results for H1 ended Sep 30, 2025; trading window opens 48h later.
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions